1. Home
  2. RGEN vs FRT Comparison

RGEN vs FRT Comparison

Compare RGEN & FRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • FRT
  • Stock Information
  • Founded
  • RGEN 1981
  • FRT 1962
  • Country
  • RGEN United States
  • FRT United States
  • Employees
  • RGEN N/A
  • FRT N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • FRT Real Estate Investment Trusts
  • Sector
  • RGEN Health Care
  • FRT Real Estate
  • Exchange
  • RGEN Nasdaq
  • FRT Nasdaq
  • Market Cap
  • RGEN 8.2B
  • FRT 9.5B
  • IPO Year
  • RGEN N/A
  • FRT N/A
  • Fundamental
  • Price
  • RGEN $143.40
  • FRT $116.69
  • Analyst Decision
  • RGEN Buy
  • FRT Buy
  • Analyst Count
  • RGEN 10
  • FRT 15
  • Target Price
  • RGEN $188.38
  • FRT $118.33
  • AVG Volume (30 Days)
  • RGEN 920.4K
  • FRT 627.1K
  • Earning Date
  • RGEN 10-29-2024
  • FRT 10-30-2024
  • Dividend Yield
  • RGEN N/A
  • FRT 3.78%
  • EPS Growth
  • RGEN N/A
  • FRT N/A
  • EPS
  • RGEN N/A
  • FRT 3.41
  • Revenue
  • RGEN $602,354,000.00
  • FRT $1,168,416,000.00
  • Revenue This Year
  • RGEN $0.08
  • FRT N/A
  • Revenue Next Year
  • RGEN $12.97
  • FRT N/A
  • P/E Ratio
  • RGEN N/A
  • FRT $34.03
  • Revenue Growth
  • RGEN N/A
  • FRT 5.11
  • 52 Week Low
  • RGEN $110.45
  • FRT $85.59
  • 52 Week High
  • RGEN $211.13
  • FRT $117.65
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 44.56
  • FRT 62.40
  • Support Level
  • RGEN $139.41
  • FRT $114.80
  • Resistance Level
  • RGEN $150.72
  • FRT $117.65
  • Average True Range (ATR)
  • RGEN 5.27
  • FRT 1.64
  • MACD
  • RGEN -0.93
  • FRT -0.07
  • Stochastic Oscillator
  • RGEN 28.36
  • FRT 70.11

About RGEN Repligen Corporation

Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.

About FRT Federal Realty Investment Trust

Federal Realty Investment Trust is a shopping center-focused retail real estate investment trust that owns high-quality properties in eight of the largest metropolitan markets. Its portfolio includes an interest in 102 properties, which includes 26.0 million square feet of retail space and over 3,100 multifamily units. Federal's retail portfolio includes grocery-anchored centers, superregional centers, power centers, and mixed-use urban centers. Federal Realty has focused on owning assets in highly desirable areas with significant growth, and as a result, the average population density and average median household income are higher for its portfolio than for any other retail REIT.

Share on Social Networks: